210 research outputs found

    Molecular Signature as Optima of Multi-Objective Function with Applications to Prediction in Oncogenomics

    Get PDF
    Náplní této práce je teoretický úvod a následné praktické zpracování tématu Molekulární signatura jako optimální multi-objektivní funkce s aplikací v predikci v onkogenomice. Úvodní kapitoly jsou zaměřeny na téma rakovina, zejména pak rakovina prsu a její podtyp triple negativní rakovinu prsu. Následuje literární přehled z oblasti optimalizačních metod, zejména se zaměřením na metaheuristické metody a problematiku strojového učení. Část se odkazuje na onkogenomiku a principy microarray a také na statistiku a s důrazem na výpočet p-hodnoty a bimodálního indexu. Praktická část je pak zaměřena na konkrétní průběh výzkumu a nalezené závěry, vedoucí k dalším krokům výzkumu. Implementace vybraných metod byla provedena v programech Matlab a R, s využitím dalších programovacích jazyků a to konkrétně programů Java a Python.Content of this work is theoretical introduction and follow-up practical processing of topic Molecular signature as optima of multi-objective function with applications to prediction in oncogenomics. Opening chapters are targeted on topic of cancer, mainly on breast cancer and its subtype Triple Negative Breast Cancer. Succeeds the literature review of optimization methods, mainly on meta-heuristic methods for multi-objective optimization and problematic of machine learning. Part is focused on the oncogenomics and on the principal of microarray and also to statistics methods with emphasis on the calculation of p-value and Bimodality Index. Practical part of work consists from concrete research and conclusions lead to next steps of research. Implementation of selected methods was realised in Matlab and R, with use of other programming languages Java and Python.

    Integrative OMICS Data-Driven Procedure Using a Derivatized Meta-Analysis Approach

    Full text link
    The wealth of high-throughput data has opened up new opportunities to analyze and describe biological processes at higher resolution, ultimately leading to a significant acceleration of scientific output using high-throughput data from the different omics layers and the generation of databases to store and report raw datasets. The great variability among the techniques and the heterogeneous methodologies used to produce this data have placed meta-analysis methods as one of the approaches of choice to correlate the resultant large-scale datasets from different research groups. Through multi-study meta-analyses, it is possible to generate results with greater statistical power compared to individual analyses. Gene signatures, biomarkers and pathways that provide new insights of a phenotype of interest have been identified by the analysis of large-scale datasets in several fields of science. However, despite all the efforts, a standardized regulation to report large-scale data and to identify the molecular targets and signaling networks is still lacking. Integrative analyses have also been introduced as complementation and augmentation for meta-analysis methodologies to generate novel hypotheses. Currently, there is no universal method established and the different methods available follow different purposes. Herein we describe a new unifying, scalable and straightforward methodology to meta-analyze different omics outputs, but also to integrate the significant outcomes into novel pathways describing biological processes of interest. The significance of using proper molecular identifiers is highlighted as well as the potential to further correlate molecules from different regulatory levels. To show the methodology's potential, a set of transcriptomic datasets are meta-analyzed as an example

    A New Feature Selection Method Based on Class Association Rule

    Full text link
    Feature selection is a key process for supervised learning algorithms. It involves discarding irrelevant attributes from the training dataset from which the models are derived. One of the vital feature selection approaches is Filtering, which often uses mathematical models to compute the relevance for each feature in the training dataset and then sorts the features into descending order based on their computed scores. However, most Filtering methods face several challenges including, but not limited to, merely considering feature-class correlation when defining a feature’s relevance; additionally, not recommending which subset of features to retain. Leaving this decision to the end-user may be impractical for multiple reasons such as the experience required in the application domain, care, accuracy, and time. In this research, we propose a new hybrid Filtering method called Class Association Rule Filter (CARF) that deals with the aforementioned issues by identifying relevant features through the Class Association Rule Mining approach and then using these rules to define weights for the available features in the training dataset. More crucially, we propose a new procedure based on mutual information within the CARF method which suggests the subset of features to be retained by the end-user, hence reducing time and effort. Empirical evaluation using small, medium, and large datasets that belong to various dissimilar domains reveals that CARF was able to reduce the dimensionality of the search space when contrasted with other common Filtering methods. More importantly, the classification models devised by the different machine learning algorithms against the subsets of features selected by CARF were highly competitive in terms of various performance measures. These results indeed reflect the quality of the subsets of features selected by CARF and show the impact of the new cut-off procedure proposed

    Computational Proteomics Using Network-Based Strategies

    Get PDF
    This thesis examines the productive application of networks towards proteomics, with a specific biological focus on liver cancer. Contempory proteomics (shot- gun) is plagued by coverage and consistency issues. These can be resolved via network-based approaches. The application of 3 classes of network-based approaches are examined: A traditional cluster based approach termed Proteomics Expansion Pipeline), a generalization of PEP termed Maxlink and a feature-based approach termed Proteomics Signature Profiling. PEP is an improvement on prevailing cluster-based approaches. It uses a state- of-the-art cluster identification algorithm as well as network-cleaning approaches to identify the critical network regions indicated by the liver cancer data set. The top PARP1 associated-cluster was identified and independently validated. Maxlink allows identification of undetected proteins based on the number of links to identified differential proteins. It is more sensitive than PEP due to more relaxed requirements. Here, the novel roles of ARRB1/2 and ACTB are identified and discussed in the context of liver cancer. Both PEP and Maxlink are unable to deal with consistency issues, PSP is the first method able to deal with both, and is termed feature-based since the network- based clusters it uses are predicted independently of the data. It is also capable of using real complexes or predicted pathway subnets. By combining pathways and complexes, a novel basis of liver cancer progression implicating nucleotide pool imbalance aggravated by mutations of key DNA repair complexes was identified. Finally, comparative evaluations suggested that pure network-based methods are vastly outperformed by feature-based network methods utilizing real complexes. This is indicative that the quality of current networks are insufficient to provide strong biological rigor for data analysis, and should be carefully evaluated before further validations.Open Acces

    Identifying the molecular components that matter: a statistical modelling approach to linking functional genomics data to cell physiology

    Get PDF
    Functional genomics technologies, in which thousands of mRNAs, proteins, or metabolites can be measured in single experiments, have contributed to reshape biological investigations. One of the most important issues in the analysis of the generated large datasets is the selection of relatively small sub-sets of variables that are predictive of the physiological state of a cell or tissue. In this thesis, a truly multivariate variable selection framework using diverse functional genomics data has been developed, characterized, and tested. This framework has also been used to prove that it is possible to predict the physiological state of the tumour from the molecular state of adjacent normal cells. This allows us to identify novel genes involved in cell to cell communication. Then, using a network inference technique networks representing cell-cell communication in prostate cancer have been inferred. The analysis of these networks has revealed interesting properties that suggests a crucial role of directional signals in controlling the interplay between normal and tumour cell to cell communication. Experimental verification performed in our laboratory has provided evidence that one of the identified genes could be a novel tumour suppressor gene. In conclusion, the findings and methods reported in this thesis have contributed to further understanding of cell to cell interaction and multivariate variable selection not only by applying and extending previous work, but also by proposing novel approaches that can be applied to any functional genomics data

    Machine learning and computational methods to identify molecular and clinical markers for complex diseases – case studies in cancer and obesity

    Get PDF
    In biomedical research, applied machine learning and bioinformatics are the essential disciplines heavily involved in translating data-driven findings into medical practice. This task is especially accomplished by developing computational tools and algorithms assisting in detection and clarification of underlying causes of the diseases. The continuous advancements in high-throughput technologies coupled with the recently promoted data sharing policies have contributed to presence of a massive wealth of data with remarkable potential to improve human health care. In concordance with this massive boost in data production, innovative data analysis tools and methods are required to meet the growing demand. The data analyzed by bioinformaticians and computational biology experts can be broadly divided into molecular and conventional clinical data categories. The aim of this thesis was to develop novel statistical and machine learning tools and to incorporate the existing state-of-the-art methods to analyze bio-clinical data with medical applications. The findings of the studies demonstrate the impact of computational approaches in clinical decision making by improving patients risk stratification and prediction of disease outcomes. This thesis is comprised of five studies explaining method development for 1) genomic data, 2) conventional clinical data and 3) integration of genomic and clinical data. With genomic data, the main focus is detection of differentially expressed genes as the most common task in transcriptome profiling projects. In addition to reviewing available differential expression tools, a data-adaptive statistical method called Reproducibility Optimized Test Statistic (ROTS) is proposed for detecting differential expression in RNA-sequencing studies. In order to prove the efficacy of ROTS in real biomedical applications, the method is used to identify prognostic markers in clear cell renal cell carcinoma (ccRCC). In addition to previously known markers, novel genes with potential prognostic and therapeutic role in ccRCC are detected. For conventional clinical data, ensemble based predictive models are developed to provide clinical decision support in treatment of patients with metastatic castration resistant prostate cancer (mCRPC). The proposed predictive models cover treatment and survival stratification tasks for both trial-based and realworld patient cohorts. Finally, genomic and conventional clinical data are integrated to demonstrate the importance of inclusion of genomic data in predictive ability of clinical models. Again, utilizing ensemble-based learners, a novel model is proposed to predict adulthood obesity using both genetic and social-environmental factors. Overall, the ultimate objective of this work is to demonstrate the importance of clinical bioinformatics and machine learning for bio-clinical marker discovery in complex disease with high heterogeneity. In case of cancer, the interpretability of clinical models strongly depends on predictive markers with high reproducibility supported by validation data. The discovery of these markers would increase chance of early detection and improve prognosis assessment and treatment choice
    corecore